The Supreme Court of Canada granted intervenor status on the six motions to intervene in the ‘promise doctrine’ proceeding: Innovative Medicines Canada and BIOTECanada (jointly); the Centre for Intellectual Property Policy (CIPP); the Canadian Generic Pharmaceutical Association (CGPA); the Fédération internationale des conseils en propriété intellectuelle (FICPI); the Intellectual Property Owners Association (IPO) and the Intellectual Property Institute of Canada (IPIC). See my earlier post on the intervenors and their materials.

My email service now includes monitoring of individual files pending at the Supreme Court, including getting updates on interim rulings and the filing of materials. You can monitoring through the email preferences page.

More information on other intellectual property proceedings at the Supreme Court are available on my Supreme Court litigation page.